Managed Care Considerations for a First-in-Class M1/M4 Muscarinic Agonist for the Treatment of Adults With Schizophrenia
Advertisement
Advertisement
Trending on AJMC
1
Advances in MASLD and MASH Care Highlight Progress and Persistent Gaps
2
New Legislation Aims to Address Transparency in PBMs as First Major Step in Reform
3
Patients With Long-Term Conditions Prefer Remote Visits for Routine Care
4
Employer Premiums and Deductibles Consume Significant Portion of Income in 19 States
5